These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 23792280

  • 1. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor.
    Nowoczyn M, Marie N, Coulbault L, Hervault M, Davis A, Hanouz JL, Allouche S.
    Neuropharmacology; 2013 Oct; 73():368-79. PubMed ID: 23792280
    [Abstract] [Full Text] [Related]

  • 2. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
    Johnson EA, Oldfield S, Braksator E, Gonzalez-Cuello A, Couch D, Hall KJ, Mundell SJ, Bailey CP, Kelly E, Henderson G.
    Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
    [Abstract] [Full Text] [Related]

  • 3. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
    Clark MJ, Traynor JR.
    J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
    [Abstract] [Full Text] [Related]

  • 4. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
    Narita M, Suzuki M, Narita M, Niikura K, Nakamura A, Miyatake M, Yajima Y, Suzuki T.
    Neuroscience; 2006 Feb; 138(2):609-19. PubMed ID: 16417975
    [Abstract] [Full Text] [Related]

  • 5. The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain.
    Sánchez-Blázquez P, Rodríguez-Muñoz M, Berrocoso E, Garzón J.
    Eur J Pharmacol; 2013 Sep 15; 716(1-3):94-105. PubMed ID: 23499699
    [Abstract] [Full Text] [Related]

  • 6. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS, Werling LL, Cox BM.
    Mol Pharmacol; 1988 May 15; 33(5):520-7. PubMed ID: 2835651
    [Abstract] [Full Text] [Related]

  • 7. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
    Baumhaker Y, Gafni M, Keren O, Sarne Y.
    Mol Pharmacol; 1993 Aug 15; 44(2):461-7. PubMed ID: 8394999
    [Abstract] [Full Text] [Related]

  • 8. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H, Wang X, Wang J, Rothman RB.
    Synapse; 2004 Jun 01; 52(3):209-17. PubMed ID: 15065220
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL, Tsai AW, Law PY.
    J Pharmacol Exp Ther; 1994 Jul 01; 270(1):177-84. PubMed ID: 8035314
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation.
    Lopez-Gimenez JF, Vilaró MT, Milligan G.
    Mol Pharmacol; 2008 Nov 01; 74(5):1278-91. PubMed ID: 18703670
    [Abstract] [Full Text] [Related]

  • 13. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
    Rodríguez-Muñoz M, de la Torre-Madrid E, Sánchez-Blázquez P, Garzón J.
    Mol Pain; 2007 Jul 17; 3():19. PubMed ID: 17634133
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May 17; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Label-free monitoring of μ-opioid receptor-mediated signaling.
    Bourassa P, Tudashki HB, Pineyro G, Grandbois M, Gendron L.
    Mol Pharmacol; 2014 Aug 17; 86(2):138-49. PubMed ID: 24874699
    [Abstract] [Full Text] [Related]

  • 18. Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine.
    Bagley EE, Chieng BC, Christie MJ, Connor M.
    Br J Pharmacol; 2005 Sep 17; 146(1):68-76. PubMed ID: 15980868
    [Abstract] [Full Text] [Related]

  • 19. Mu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons.
    Walwyn WM, Wei W, Xie CW, Chiu K, Kieffer BL, Evans CJ, Maidment NT.
    Neuroscience; 2006 Oct 13; 142(2):493-503. PubMed ID: 16887280
    [Abstract] [Full Text] [Related]

  • 20. Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5.
    Beaudry H, Mercier-Blais AA, Delaygue C, Lavoie C, Parent JL, Neugebauer W, Gendron L.
    Br J Pharmacol; 2015 May 13; 172(10):2573-87. PubMed ID: 25598508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.